Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDTraws Pharma, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$8.04 | -$8.04 | -$8.04 |
| Q2 2025 | 1 | -$8.75 | -$8.75 | -$8.75 |
| Q3 2025 | 1 | -$9.16 | -$9.16 | -$9.16 |
| Q4 2025 | 1 | -$9.56 | -$9.56 | -$9.56 |
Traws Pharma, Inc. Earnings Date And Information
Traws Pharma, Inc. last posted its earnings results on Thursday, November 14th, 2024. The company reported $-8.81 earnings per share for the quarter, missing analysts' consensus estimates of $-6.25 by $2.56. The company had revenue of 57,000 for the quarter and had revenue of 226,000 for the year. Traws Pharma, Inc. has generated $-1 earnings per share over the last year ($-0.9 diluted earnings per share) and currently has a price-to-earnings ratio of -0.02. Traws Pharma, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 31st, 2025 based on prior year's report dates.
Traws Pharma, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/30/2024 | Q3 2024 | N/A | -$8.81 | N/A | $60,000 | $57,000 |
| 06/28/2024 | Q2 2024 | N/A | -$4.87 | N/A | $60,000 | $57,000 |
| 03/29/2024 | Q1 2024 | N/A | -$0.24 | N/A | N/A | $56,000 |
| 12/30/2023 | Q4 2023 | N/A | -$0.20 | N/A | N/A | $56,000 |
| 09/29/2023 | Q3 2023 | N/A | -$0.23 | N/A | $69,250 | $57,000 |
| 06/29/2023 | Q2 2023 | N/A | -$0.20 | N/A | $69,250 | $57,000 |
| 03/30/2023 | Q1 2023 | N/A | -$0.28 | N/A | N/A | $56,000 |
| 12/29/2022 | Q4 2022 | N/A | -$0.26 | N/A | N/A | $56,000 |
| 09/28/2022 | Q3 2022 | N/A | -$0.26 | N/A | $73,667 | $57,000 |
| 06/28/2022 | Q2 2022 | N/A | -$0.19 | N/A | $73,000 | $57,000 |
| 03/29/2022 | Q1 2022 | N/A | -$0.20 | N/A | N/A | $56,000 |
| 12/29/2021 | Q4 2021 | N/A | -$0.18 | N/A | N/A | $56,000 |
| 09/28/2021 | Q3 2021 | N/A | -$0.22 | N/A | $53,333 | $57,000 |
| 06/28/2021 | Q2 2021 | N/A | -$0.27 | N/A | $20,000 | $57,000 |
| 03/31/2021 | Q1 2021 | N/A | -$0.32 | N/A | N/A | $56,000 |
| 12/31/2020 | Q4 2020 | N/A | $0.00 | N/A | N/A | $57,000 |
| 09/30/2020 | Q3 2020 | N/A | -$0.52 | N/A | $1.39 M | $66,000 |
| 06/30/2020 | Q2 2020 | N/A | -$0.65 | N/A | $173,000 | $56,000 |
| 03/31/2020 | Q1 2020 | N/A | -$0.48 | N/A | N/A | $52,000 |
| 12/31/2019 | Q4 2019 | N/A | $0.00 | N/A | N/A | $30,000 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Traws Pharma, Inc. Earnings: FAQ's
Traws Pharma, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 31st, 2025 based offlast year's report dates.
The conference call for Traws Pharma, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Traws Pharma, Inc.'s latest earnings report can be read online.
Traws Pharma, Inc. (:TRAW) has a recorded annual revenue of $226,000.
Traws Pharma, Inc. (:TRAW) has a recorded net income of $-18,948,000.Traws Pharma, Inc. has generated $-0.9 earnings per share over the last four quarters.
Traws Pharma, Inc. (:TRAW) has a price-to-earnings ratio of -0.02 and price/earnings-to-growth ratio is 0.